CN1125338C - Blood separating colloid - Google Patents

Blood separating colloid Download PDF

Info

Publication number
CN1125338C
CN1125338C CN 00115944 CN00115944A CN1125338C CN 1125338 C CN1125338 C CN 1125338C CN 00115944 CN00115944 CN 00115944 CN 00115944 A CN00115944 A CN 00115944A CN 1125338 C CN1125338 C CN 1125338C
Authority
CN
China
Prior art keywords
blood
blood separating
separating colloid
silicon dioxide
separating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 00115944
Other languages
Chinese (zh)
Other versions
CN1281145A (en
Inventor
邓兆群
杨小钢
邱方城
周新
屈雪菊
刘芳
曹小春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUBEI MEDICAL UNIV
Original Assignee
HUBEI MEDICAL UNIV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUBEI MEDICAL UNIV filed Critical HUBEI MEDICAL UNIV
Priority to CN 00115944 priority Critical patent/CN1125338C/en
Publication of CN1281145A publication Critical patent/CN1281145A/en
Application granted granted Critical
Publication of CN1125338C publication Critical patent/CN1125338C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to blood separating gel which is a product obtained through the reaction of a hydrocarbon compound with macromolecules and silicon dioxide at the temperature of 100 to 200 DEG C. The specific weight D20 is from 1.04 to 1.05, and the viscosity is from 20 to 80*10<4>CP at 20 DEG C. The blood separating gel has the advantages of few raw materials and low cost. The blood separating gel is added to a blood sampling tube after sterilization and coagulation promotion, and thus, serum is separated from blood cells. Large quantities of clinical experiments prove that the separating effect is good and the separating cost is low.

Description

Blood separating colloid
The present invention relates to a kind of clinical examination process that is used for, with serum in the blood and blood cell separation gel.
In clinical examination, adopt blood separating colloid that the serum in the blood in the heparin tube is separated with blood cell usually.Existing blood separating colloid has a lot, the blood separating colloid that is distributed as U.S. Pat P3.780.935, USP4.018.564, USP4.387.031, be to prepare with silicone oil, silicon dioxide, polyvinyl chloride powder, after they place a period of time, viscosity can change, thereby the quality of influence separation.USP4.310.430, USP4.426.290 have announced the blood separating colloid that is mixed with by tygon hydrocarbon maleate and silicon dioxide." a kind of serum separation gel and adopt preparation method to pipe " (application number 93112002.0) disclosed serum separation gel is by silicon rubber, and macromolecular hydrocarbon, mercapto glue are formulated.Wherein the silicon rubber valency is expensive, causes the cost height of blood separating colloid.It adopts dewatering silica gel is raw material, needs to have the carrier method of the silica flour of necessarily required silicon dioxide gained behind the bowl mill mill with preparative chromatography, obtains giving preparation again behind the dewatering silica gel by preparation with trimethyl chlorosilane.
Purpose of the present invention aims to provide the blood separating colloid that a kind of cost is low, can directly directly prepare with silicon dioxide.
The implementation of the object of the invention is, blood separating colloid be by weight ratio be the silicon dioxide of the macromolecular hydrocarbon of 70-80% and 20-30% in 100 ℃-200 ℃ products of reaction down, its proportion is D 201.04-1.05, viscosity (20 ℃) is 20-80 * 10 4CP.
Wherein macromolecular hydrocarbon comprises: 20 #-60 #In machinery oil, whiteruss, the polyisobutylene one or more.
The present invention only adopts inexpensive macromolecular hydrocarbon and silicon dioxide, after mixing in required ratio, reacts 1-3 hour down at 100 ℃-200 ℃, promptly gets blood separating colloid.This blood separating colloid production technology is simple, cost is low, preservation effect is good.
This blood glue carries out clinical practice in the court clinical laboratory, blood effect separator well.Clinical laboratory of People's Hospital, Shiyan City has carried out preliminary clinical testing with this blood separating colloid, and the result shows that the short effect with fixed attention and the blood separation of this blood separating colloid are effective, and be close with external like product.
Enumerate the specific embodiment of the invention below:
Example 1, to get weight ratio be 30% polyisobutylene, 50% whiteruss mixing, 100 ℃-200 ℃ reactions 3 hours down, adds 20% silicon dioxide, fully stir this blood separating colloid.During check, this blood separation of 0.5-1g liquid is added in the heparin tube, in heparin tube, add blood sample, after the blood coagulation, in 1000G centrifugal 10 minutes, promptly between serum and clot, form separation layer after the separation.
Example 2, get weight ratio be 30% polyisobutylene, 30% 20 #-60 #Machinery oil adds 30% silicon dioxide 100 ℃-200 ℃ down reactions 3 hours, fully stir this blood separating colloid.Application is with example 1.

Claims (1)

1, blood separating colloid, it is characterized in that be by weight ratio be the silicon dioxide of the macromolecular hydrocarbon of 70-80% and 20-30% in 100 ℃-200 ℃ products of reflection down, its proportion is D 201.04-1.05, viscosity is 20-80 * 10 20 ℃ the time 4CP, wherein macromolecular hydrocarbon comprises: 20 #-60 #In machinery oil, whiteruss, the polyisobutylene one or more.
CN 00115944 2000-08-08 2000-08-08 Blood separating colloid Expired - Fee Related CN1125338C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00115944 CN1125338C (en) 2000-08-08 2000-08-08 Blood separating colloid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00115944 CN1125338C (en) 2000-08-08 2000-08-08 Blood separating colloid

Publications (2)

Publication Number Publication Date
CN1281145A CN1281145A (en) 2001-01-24
CN1125338C true CN1125338C (en) 2003-10-22

Family

ID=4585384

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00115944 Expired - Fee Related CN1125338C (en) 2000-08-08 2000-08-08 Blood separating colloid

Country Status (1)

Country Link
CN (1) CN1125338C (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100341599C (en) * 2005-09-19 2007-10-10 陈平谦 Inertia glue
EP2360470A4 (en) * 2008-11-07 2013-01-02 Hitachi Chemical Co Ltd Blood serum or blood plasma separating material and blood-collecting tube using same
CN101570637B (en) * 2009-06-02 2011-12-14 广州标美药用辅料有限公司 Organic silicon separation gel and preparation method and application thereof
CN102309870A (en) * 2011-06-17 2012-01-11 上海科华检验医学产品有限公司 Blood separation gel used for blood collection vessel and preparation method thereof
CN102212514B (en) * 2011-06-17 2012-10-24 上海科华检验医学产品有限公司 Blood coagulant for blood collection container
CN102872616B (en) * 2012-09-26 2014-10-01 成都众睿达科技有限公司 Blood separating gel and preparation method thereof
CN103293049A (en) * 2013-05-27 2013-09-11 苏州扬清芯片科技有限公司 Serum separation method and serum separation device
CN103585787A (en) * 2013-11-15 2014-02-19 中国科学院长春应用化学研究所 Application of suspension isolation balls in separation gel blood collection tube
US10677778B2 (en) * 2015-06-10 2020-06-09 Sekisui Medical Co., Ltd. Serum- or plasma-separating composition, blood-test container, and method of stabilizing serum- or plasma-separating composition
CN107233751A (en) * 2017-06-30 2017-10-10 常州亚环环保科技有限公司 A kind of stable low viscosity blood separating colloid and preparation method thereof

Also Published As

Publication number Publication date
CN1281145A (en) 2001-01-24

Similar Documents

Publication Publication Date Title
CN1125338C (en) Blood separating colloid
Joye et al. Process for selective extraction of pectins from plant material by differential pH
Gottschalk et al. V. The significance of N-acetylneuraminic acid for the viscosity of ovine submaxillary gland mucoprotein
US4640909A (en) Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction
CN102690387B (en) Resin used for serum separating gel, serum separating gel and preparation methods of resin used for serum separating gel
EP4321619A1 (en) Method for producing tagatose from biomimetic silicon mineralized microcapsule immobilized multi-enzyme
CN101250270A (en) Crosslinking reactions
Glasser et al. Silicate species in solution. Part 1. Experimental observations
Franceschi et al. Aggregation properties of the 1, 25-dihydroxyvitamin D3 receptor from chick intestinal cytosol.
CN102309870A (en) Blood separation gel used for blood collection vessel and preparation method thereof
CN1096373A (en) The preparation method of a kind of serum separation gel and heparin tube
CN103773000A (en) Method for preparing star-shaped styrene thermoplastic elastomer
CN104531808B (en) A kind of preparation method of cyclodextrin
CN100341599C (en) Inertia glue
CN102952165B (en) A kind of method extracting L-arabinose from xylose mother liquid
CN101570637B (en) Organic silicon separation gel and preparation method and application thereof
CN102924503B (en) A kind of RAFT chain transfer agents and preparation and application thereof containing silane
JPS58103502A (en) Production of polysaccharide
CN106977618B (en) Method for extracting diutan from diutan fermentation liquor
Serrano et al. The removal of the carboxy-terminal region of tubulin favors its vinblastine-induced aggregation into spiral-like structures
Arnold A column method for enzymic characterization of coarse cellular fractions: Application to insoluble β-fructofuranosidase from grape
CN111733210A (en) Method for rapidly determining rice enzymolysis quantity in high flux manner
JPH0484854A (en) Sarcocarp-containing yoghurt
CN1033977C (en) Drying process for producing acid modified starch
SU1182075A1 (en) Method of activating bakery compressed yeast and yeast cells of yeast milk

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee